Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

97
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
97
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secretome and Pathway Analysis of Stress Induced Disc Degeneration In Vitro.

JOR spine·2026
Same author

Diagnosis of aseptic loosening after hip arthroplasty : international Delphi consensus.

The bone & joint journal·2026
Same author

Development of a Novel Holistic Assessment Strategy of TAVI-Induced Flow Restoration via Dimensionality Reduction Techniques.

Cardiovascular engineering and technology·2026
Same author

Validation of Aortic Blood Flow Simulations During Extracorporeal Circulation Using Phase Contrast Magnetic Resonance Imaging.

Artificial organs·2026
Same author

Interpretable Machine Learning for Feature-Based Classification of Platelet Activation in Rotary Blood Pumps.

Cardiovascular engineering and technology·2026
Same author

Noninvasive Predictive Model for Rapid Hemodynamic Optimization During Mechanical Circulatory Support.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Related Experiment Video

Updated: Dec 20, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

4.2K

A Novel Multiplex Based Platform for Osteoarthritis Drug Candidate Evaluation.

Michael Neidlin1, Efthymia Chantzi2, George Macheras3

  • 1Department of Mechanical Engineering, National Technical University of Athens, Heroon Polytechniou 9, 15780, Zografou, Greece.

Annals of Biomedical Engineering
|May 31, 2020
PubMed
Summary

This study developed a new platform to test osteoarthritis drugs, identifying a promising treatment that improved cartilage biomechanics and reduced degradation. The approach connects molecular responses to tissue-level changes for better drug evaluation.

Keywords:
Cartilage biomechanicsCombinatorial drug treatmentIn vitro modelMultiplex proteomicsSystems biology

More Related Videos

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
09:13

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis

Published on: January 5, 2024

1.7K
Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
10:35

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction

Published on: December 3, 2017

11.4K

Related Experiment Videos

Last Updated: Dec 20, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

4.2K
Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
09:13

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis

Published on: January 5, 2024

1.7K
Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
10:35

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction

Published on: December 3, 2017

11.4K

Area of Science:

  • Biomedical Engineering
  • Pharmacology
  • Orthopedics

Background:

  • Osteoarthritis (OA) involves irreversible cartilage degradation with limited therapeutic options.
  • Current drug development often overlooks OA's biological complexity.
  • Systems-based approaches are needed for effective OA drug discovery.

Purpose of the Study:

  • To evaluate drug candidates for osteoarthritis using a novel ex vivo cartilage degradation model.
  • To identify effective drug combinations through exhaustive combinatorial experiments.
  • To link molecular-level chondrocyte responses to tissue-level biomechanical changes.

Main Methods:

  • Utilized an ex vivo cartilage degradation model measuring 27 protein releases.
  • Screened 9 drug candidates, followed by combinatorial testing of the top 3.
  • Validated promising candidates using finite element modeling (FEM) and glycosaminoglycan (GAG) release quantification.

Main Results:

  • Identified a top-performing drug candidate that enhanced Young's modulus and reduced hydraulic permeability and GAG release.
  • The least promising candidate showed opposite effects on these properties.
  • Demonstrated a correlation between molecular responses and biomechanical property changes.

Conclusions:

  • The novel drug evaluation platform shows potential for identifying effective OA treatments.
  • Exhaustive combination experiments are valuable for optimizing therapeutic strategies.
  • Connecting molecular and biomechanical data provides a comprehensive understanding of treatment efficacy.